nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2D6—Hydroxyurea—head and neck cancer	0.108	0.254	CbGbCtD
Nicardipine—CYP2C8—Fluorouracil—head and neck cancer	0.0648	0.152	CbGbCtD
Nicardipine—CYP3A5—Docetaxel—head and neck cancer	0.0515	0.121	CbGbCtD
Nicardipine—CYP2C9—Fluorouracil—head and neck cancer	0.0452	0.106	CbGbCtD
Nicardipine—ABCB1—Vinblastine—head and neck cancer	0.0407	0.0953	CbGbCtD
Nicardipine—CYP2D6—Vinblastine—head and neck cancer	0.0383	0.0898	CbGbCtD
Nicardipine—ABCB1—Docetaxel—head and neck cancer	0.0335	0.0785	CbGbCtD
Nicardipine—CYP3A4—Vinblastine—head and neck cancer	0.0244	0.0571	CbGbCtD
Nicardipine—CYP3A4—Docetaxel—head and neck cancer	0.0201	0.0471	CbGbCtD
Nicardipine—CALM1—superior cervical ganglion—head and neck cancer	0.0158	0.0894	CbGeAlD
Nicardipine—CACNA1D—cochlea—head and neck cancer	0.0134	0.0759	CbGeAlD
Nicardipine—CACNA1D—internal ear—head and neck cancer	0.0127	0.0719	CbGeAlD
Nicardipine—CALM1—trigeminal nerve—head and neck cancer	0.0089	0.0505	CbGeAlD
Nicardipine—CACNA1D—ear—head and neck cancer	0.00855	0.0485	CbGeAlD
Nicardipine—CALM1—cranial nerve—head and neck cancer	0.00634	0.036	CbGeAlD
Nicardipine—CALM2—ear—head and neck cancer	0.00519	0.0294	CbGeAlD
Nicardipine—CALM1—ear—head and neck cancer	0.00517	0.0293	CbGeAlD
Nicardipine—Pericarditis—Fluorouracil—head and neck cancer	0.00466	0.0413	CcSEcCtD
Nicardipine—CHRM3—exocrine gland—head and neck cancer	0.00293	0.0166	CbGeAlD
Nicardipine—CALM2—exocrine gland—head and neck cancer	0.00287	0.0163	CbGeAlD
Nicardipine—CALM1—exocrine gland—head and neck cancer	0.00286	0.0162	CbGeAlD
Nicardipine—CALM2—hair follicle—head and neck cancer	0.00274	0.0155	CbGeAlD
Nicardipine—PDE1B—thyroid gland—head and neck cancer	0.00266	0.0151	CbGeAlD
Nicardipine—Deep vein thrombosis—Docetaxel—head and neck cancer	0.00239	0.0212	CcSEcCtD
Nicardipine—PDE1B—head—head and neck cancer	0.00236	0.0134	CbGeAlD
Nicardipine—CHRM5—epithelium—head and neck cancer	0.00228	0.0129	CbGeAlD
Nicardipine—PDE1A—thyroid gland—head and neck cancer	0.00223	0.0127	CbGeAlD
Nicardipine—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00222	0.0197	CcSEcCtD
Nicardipine—CALM2—mouth—head and neck cancer	0.00215	0.0122	CbGeAlD
Nicardipine—CALM1—mouth—head and neck cancer	0.00214	0.0121	CbGeAlD
Nicardipine—ADRA1D—epithelium—head and neck cancer	0.00204	0.0116	CbGeAlD
Nicardipine—Throat sore—Docetaxel—head and neck cancer	0.00202	0.0179	CcSEcCtD
Nicardipine—CACNA1C—connective tissue—head and neck cancer	0.002	0.0113	CbGeAlD
Nicardipine—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.002	0.0177	CcSEcCtD
Nicardipine—PDE1A—head—head and neck cancer	0.00198	0.0112	CbGeAlD
Nicardipine—Face oedema—Hydroxyurea—head and neck cancer	0.00196	0.0174	CcSEcCtD
Nicardipine—CALM3—parotid gland—head and neck cancer	0.0019	0.0108	CbGeAlD
Nicardipine—Angina pectoris—Vinblastine—head and neck cancer	0.00188	0.0166	CcSEcCtD
Nicardipine—CALM2—neck—head and neck cancer	0.00184	0.0104	CbGeAlD
Nicardipine—CALM1—neck—head and neck cancer	0.00183	0.0104	CbGeAlD
Nicardipine—CALM3—saliva-secreting gland—head and neck cancer	0.00182	0.0103	CbGeAlD
Nicardipine—CHRM4—head—head and neck cancer	0.00181	0.0103	CbGeAlD
Nicardipine—CHRM1—parotid gland—head and neck cancer	0.00171	0.00968	CbGeAlD
Nicardipine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00169	0.015	CcSEcCtD
Nicardipine—Myocardial infarction—Vinblastine—head and neck cancer	0.00168	0.0149	CcSEcCtD
Nicardipine—PDE1B—lymph node—head and neck cancer	0.00165	0.00938	CbGeAlD
Nicardipine—CACNB2—thyroid gland—head and neck cancer	0.00165	0.00933	CbGeAlD
Nicardipine—CHRM1—saliva-secreting gland—head and neck cancer	0.00163	0.00927	CbGeAlD
Nicardipine—Oropharyngeal pain—Docetaxel—head and neck cancer	0.0016	0.0142	CcSEcCtD
Nicardipine—CACNA2D1—thyroid gland—head and neck cancer	0.00155	0.00877	CbGeAlD
Nicardipine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00153	0.0136	CcSEcCtD
Nicardipine—CALM2—parotid gland—head and neck cancer	0.00149	0.00848	CbGeAlD
Nicardipine—CHRM3—saliva-secreting gland—head and neck cancer	0.00146	0.00829	CbGeAlD
Nicardipine—CACNB2—head—head and neck cancer	0.00146	0.00828	CbGeAlD
Nicardipine—Injection site reaction—Docetaxel—head and neck cancer	0.00145	0.0128	CcSEcCtD
Nicardipine—CACNA1D—thyroid gland—head and neck cancer	0.00144	0.00816	CbGeAlD
Nicardipine—CALM2—saliva-secreting gland—head and neck cancer	0.00143	0.00812	CbGeAlD
Nicardipine—CALM1—saliva-secreting gland—head and neck cancer	0.00142	0.00808	CbGeAlD
Nicardipine—CHRM5—head—head and neck cancer	0.00142	0.00803	CbGeAlD
Nicardipine—CALM3—trachea—head and neck cancer	0.00141	0.00797	CbGeAlD
Nicardipine—PDE1A—lymph node—head and neck cancer	0.00139	0.00786	CbGeAlD
Nicardipine—CACNA2D1—head—head and neck cancer	0.00137	0.00778	CbGeAlD
Nicardipine—CALM2—connective tissue—head and neck cancer	0.00132	0.00746	CbGeAlD
Nicardipine—CALM1—connective tissue—head and neck cancer	0.00131	0.00742	CbGeAlD
Nicardipine—ADRA1B—head—head and neck cancer	0.00129	0.00734	CbGeAlD
Nicardipine—CACNA1D—head—head and neck cancer	0.00128	0.00724	CbGeAlD
Nicardipine—ADRA1D—head—head and neck cancer	0.00127	0.00718	CbGeAlD
Nicardipine—CHRM1—trachea—head and neck cancer	0.00126	0.00715	CbGeAlD
Nicardipine—CALM2—epithelium—head and neck cancer	0.00125	0.00708	CbGeAlD
Nicardipine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00124	0.011	CcSEcCtD
Nicardipine—CALM1—epithelium—head and neck cancer	0.00124	0.00705	CbGeAlD
Nicardipine—Angina pectoris—Fluorouracil—head and neck cancer	0.00123	0.0109	CcSEcCtD
Nicardipine—Malaise—Vinblastine—head and neck cancer	0.00121	0.0107	CcSEcCtD
Nicardipine—Vertigo—Vinblastine—head and neck cancer	0.00121	0.0107	CcSEcCtD
Nicardipine—Amlodipine—CYP1A1—head and neck cancer	0.00118	0.528	CrCbGaD
Nicardipine—CACNA1C—head—head and neck cancer	0.00118	0.00668	CbGeAlD
Nicardipine—ADRA1A—epithelium—head and neck cancer	0.00117	0.00664	CbGeAlD
Nicardipine—Hypertension—Vinblastine—head and neck cancer	0.00116	0.0103	CcSEcCtD
Nicardipine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00114	0.0101	CcSEcCtD
Nicardipine—Discomfort—Vinblastine—head and neck cancer	0.00113	0.01	CcSEcCtD
Nicardipine—Hot flush—Docetaxel—head and neck cancer	0.00113	0.01	CcSEcCtD
Nicardipine—Menopausal symptoms—Docetaxel—head and neck cancer	0.00112	0.00993	CcSEcCtD
Nicardipine—Atrial fibrillation—Docetaxel—head and neck cancer	0.00111	0.00989	CcSEcCtD
Nicardipine—CALM3—thyroid gland—head and neck cancer	0.00111	0.00631	CbGeAlD
Nicardipine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00111	0.00986	CcSEcCtD
Nicardipine—Myocardial infarction—Fluorouracil—head and neck cancer	0.0011	0.0098	CcSEcCtD
Nicardipine—CALM2—trachea—head and neck cancer	0.0011	0.00626	CbGeAlD
Nicardipine—Malaise—Hydroxyurea—head and neck cancer	0.0011	0.00979	CcSEcCtD
Nicardipine—CALM1—trachea—head and neck cancer	0.0011	0.00623	CbGeAlD
Nicardipine—Conjunctivitis—Fluorouracil—head and neck cancer	0.0011	0.00972	CcSEcCtD
Nicardipine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00107	0.00952	CcSEcCtD
Nicardipine—Sinusitis—Fluorouracil—head and neck cancer	0.00106	0.00938	CcSEcCtD
Nicardipine—Nifedipine—CYP1A1—head and neck cancer	0.00106	0.472	CrCbGaD
Nicardipine—Discomfort—Hydroxyurea—head and neck cancer	0.00103	0.00913	CcSEcCtD
Nicardipine—CACNB2—lymph node—head and neck cancer	0.00102	0.0058	CbGeAlD
Nicardipine—Rhinitis—Fluorouracil—head and neck cancer	0.00101	0.009	CcSEcCtD
Nicardipine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00101	0.00893	CcSEcCtD
Nicardipine—Oedema—Hydroxyurea—head and neck cancer	0.000998	0.00886	CcSEcCtD
Nicardipine—Infection—Hydroxyurea—head and neck cancer	0.000992	0.0088	CcSEcCtD
Nicardipine—Paraesthesia—Vinblastine—head and neck cancer	0.000983	0.00873	CcSEcCtD
Nicardipine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000978	0.00868	CcSEcCtD
Nicardipine—CHRM2—head—head and neck cancer	0.000972	0.00551	CbGeAlD
Nicardipine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000964	0.00856	CcSEcCtD
Nicardipine—CALM2—lymphoid tissue—head and neck cancer	0.000962	0.00545	CbGeAlD
Nicardipine—CACNA2D1—lymph node—head and neck cancer	0.00096	0.00545	CbGeAlD
Nicardipine—CALM1—lymphoid tissue—head and neck cancer	0.000957	0.00543	CbGeAlD
Nicardipine—Constipation—Vinblastine—head and neck cancer	0.000936	0.00831	CcSEcCtD
Nicardipine—Pain—Vinblastine—head and neck cancer	0.000936	0.00831	CcSEcCtD
Nicardipine—Feeling abnormal—Vinblastine—head and neck cancer	0.000902	0.00801	CcSEcCtD
Nicardipine—ADRA1A—lymphoid tissue—head and neck cancer	0.000902	0.00512	CbGeAlD
Nicardipine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000895	0.00795	CcSEcCtD
Nicardipine—CACNA1D—lymph node—head and neck cancer	0.000894	0.00507	CbGeAlD
Nicardipine—CHRM3—thyroid gland—head and neck cancer	0.000892	0.00506	CbGeAlD
Nicardipine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00089	0.0079	CcSEcCtD
Nicardipine—Angina pectoris—Docetaxel—head and neck cancer	0.000888	0.00789	CcSEcCtD
Nicardipine—Somnolence—Hydroxyurea—head and neck cancer	0.000888	0.00788	CcSEcCtD
Nicardipine—CHRM1—head—head and neck cancer	0.000885	0.00502	CbGeAlD
Nicardipine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000879	0.0078	CcSEcCtD
Nicardipine—CALM2—thyroid gland—head and neck cancer	0.000873	0.00495	CbGeAlD
Nicardipine—CALM1—thyroid gland—head and neck cancer	0.000869	0.00493	CbGeAlD
Nicardipine—Abdominal pain—Vinblastine—head and neck cancer	0.000865	0.00768	CcSEcCtD
Nicardipine—Constipation—Hydroxyurea—head and neck cancer	0.000854	0.00758	CcSEcCtD
Nicardipine—Pain—Hydroxyurea—head and neck cancer	0.000854	0.00758	CcSEcCtD
Nicardipine—Vision blurred—Fluorouracil—head and neck cancer	0.00083	0.00737	CcSEcCtD
Nicardipine—CACNA1C—lymph node—head and neck cancer	0.000825	0.00468	CbGeAlD
Nicardipine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000823	0.0073	CcSEcCtD
Nicardipine—Hypersensitivity—Vinblastine—head and neck cancer	0.000807	0.00716	CcSEcCtD
Nicardipine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000802	0.00712	CcSEcCtD
Nicardipine—Myocardial infarction—Docetaxel—head and neck cancer	0.000797	0.00708	CcSEcCtD
Nicardipine—CHRM3—head—head and neck cancer	0.000792	0.00449	CbGeAlD
Nicardipine—Conjunctivitis—Docetaxel—head and neck cancer	0.00079	0.00702	CcSEcCtD
Nicardipine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000789	0.00701	CcSEcCtD
Nicardipine—Asthenia—Vinblastine—head and neck cancer	0.000785	0.00697	CcSEcCtD
Nicardipine—CALM2—head—head and neck cancer	0.000775	0.00439	CbGeAlD
Nicardipine—CALM1—head—head and neck cancer	0.000771	0.00437	CbGeAlD
Nicardipine—Myalgia—Fluorouracil—head and neck cancer	0.00075	0.00665	CcSEcCtD
Nicardipine—Chest pain—Fluorouracil—head and neck cancer	0.00075	0.00665	CcSEcCtD
Nicardipine—Diarrhoea—Vinblastine—head and neck cancer	0.000749	0.00665	CcSEcCtD
Nicardipine—Discomfort—Fluorouracil—head and neck cancer	0.000741	0.00657	CcSEcCtD
Nicardipine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000736	0.00653	CcSEcCtD
Nicardipine—Rhinitis—Docetaxel—head and neck cancer	0.000732	0.0065	CcSEcCtD
Nicardipine—ADRA1A—head—head and neck cancer	0.000727	0.00412	CbGeAlD
Nicardipine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000726	0.00645	CcSEcCtD
Nicardipine—Confusional state—Fluorouracil—head and neck cancer	0.000725	0.00643	CcSEcCtD
Nicardipine—Dizziness—Vinblastine—head and neck cancer	0.000724	0.00643	CcSEcCtD
Nicardipine—Oedema peripheral—Docetaxel—head and neck cancer	0.000719	0.00638	CcSEcCtD
Nicardipine—Oedema—Fluorouracil—head and neck cancer	0.000719	0.00638	CcSEcCtD
Nicardipine—Asthenia—Hydroxyurea—head and neck cancer	0.000716	0.00636	CcSEcCtD
Nicardipine—CYP2B6—lymphoid tissue—head and neck cancer	0.000715	0.00405	CbGeAlD
Nicardipine—Infection—Fluorouracil—head and neck cancer	0.000714	0.00634	CcSEcCtD
Nicardipine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000704	0.00625	CcSEcCtD
Nicardipine—Visual impairment—Docetaxel—head and neck cancer	0.000704	0.00625	CcSEcCtD
Nicardipine—Tachycardia—Fluorouracil—head and neck cancer	0.000701	0.00623	CcSEcCtD
Nicardipine—Vomiting—Vinblastine—head and neck cancer	0.000696	0.00618	CcSEcCtD
Nicardipine—CALM3—lymph node—head and neck cancer	0.000691	0.00392	CbGeAlD
Nicardipine—Headache—Vinblastine—head and neck cancer	0.000686	0.00609	CcSEcCtD
Nicardipine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000683	0.00606	CcSEcCtD
Nicardipine—Flushing—Docetaxel—head and neck cancer	0.000678	0.00601	CcSEcCtD
Nicardipine—Hypotension—Fluorouracil—head and neck cancer	0.000671	0.00596	CcSEcCtD
Nicardipine—CYP2E1—lymphoid tissue—head and neck cancer	0.000671	0.0038	CbGeAlD
Nicardipine—Dizziness—Hydroxyurea—head and neck cancer	0.00066	0.00586	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000655	0.00581	CcSEcCtD
Nicardipine—Nausea—Vinblastine—head and neck cancer	0.00065	0.00577	CcSEcCtD
Nicardipine—Insomnia—Fluorouracil—head and neck cancer	0.00065	0.00577	CcSEcCtD
Nicardipine—Paraesthesia—Fluorouracil—head and neck cancer	0.000645	0.00573	CcSEcCtD
Nicardipine—Dyspnoea—Fluorouracil—head and neck cancer	0.000641	0.00569	CcSEcCtD
Nicardipine—Somnolence—Fluorouracil—head and neck cancer	0.000639	0.00567	CcSEcCtD
Nicardipine—Vomiting—Hydroxyurea—head and neck cancer	0.000635	0.00564	CcSEcCtD
Nicardipine—Dyspepsia—Fluorouracil—head and neck cancer	0.000633	0.00562	CcSEcCtD
Nicardipine—Rash—Hydroxyurea—head and neck cancer	0.000629	0.00559	CcSEcCtD
Nicardipine—Dermatitis—Hydroxyurea—head and neck cancer	0.000629	0.00558	CcSEcCtD
Nicardipine—Headache—Hydroxyurea—head and neck cancer	0.000625	0.00555	CcSEcCtD
Nicardipine—Pain—Fluorouracil—head and neck cancer	0.000615	0.00546	CcSEcCtD
Nicardipine—CYP2E1—thyroid gland—head and neck cancer	0.000609	0.00346	CbGeAlD
Nicardipine—Nausea—Hydroxyurea—head and neck cancer	0.000593	0.00526	CcSEcCtD
Nicardipine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000592	0.00526	CcSEcCtD
Nicardipine—CYP2B6—head—head and neck cancer	0.000576	0.00327	CbGeAlD
Nicardipine—Syncope—Docetaxel—head and neck cancer	0.00057	0.00506	CcSEcCtD
Nicardipine—Body temperature increased—Fluorouracil—head and neck cancer	0.000568	0.00504	CcSEcCtD
Nicardipine—Palpitations—Docetaxel—head and neck cancer	0.000562	0.00499	CcSEcCtD
Nicardipine—Loss of consciousness—Docetaxel—head and neck cancer	0.000559	0.00496	CcSEcCtD
Nicardipine—Hypertension—Docetaxel—head and neck cancer	0.000549	0.00487	CcSEcCtD
Nicardipine—CALM2—lymph node—head and neck cancer	0.000543	0.00308	CbGeAlD
Nicardipine—Chest pain—Docetaxel—head and neck cancer	0.000541	0.0048	CcSEcCtD
Nicardipine—Myalgia—Docetaxel—head and neck cancer	0.000541	0.0048	CcSEcCtD
Nicardipine—Arthralgia—Docetaxel—head and neck cancer	0.000541	0.0048	CcSEcCtD
Nicardipine—CYP2E1—head—head and neck cancer	0.000541	0.00307	CbGeAlD
Nicardipine—CALM1—lymph node—head and neck cancer	0.00054	0.00306	CbGeAlD
Nicardipine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000529	0.0047	CcSEcCtD
Nicardipine—Dry mouth—Docetaxel—head and neck cancer	0.000529	0.0047	CcSEcCtD
Nicardipine—Confusional state—Docetaxel—head and neck cancer	0.000523	0.00464	CcSEcCtD
Nicardipine—Oedema—Docetaxel—head and neck cancer	0.000519	0.0046	CcSEcCtD
Nicardipine—Infection—Docetaxel—head and neck cancer	0.000515	0.00457	CcSEcCtD
Nicardipine—Shock—Docetaxel—head and neck cancer	0.00051	0.00453	CcSEcCtD
Nicardipine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000508	0.00451	CcSEcCtD
Nicardipine—Tachycardia—Docetaxel—head and neck cancer	0.000506	0.00449	CcSEcCtD
Nicardipine—ABCB1—epithelium—head and neck cancer	0.000496	0.00281	CbGeAlD
Nicardipine—Diarrhoea—Fluorouracil—head and neck cancer	0.000492	0.00436	CcSEcCtD
Nicardipine—Hypotension—Docetaxel—head and neck cancer	0.000485	0.0043	CcSEcCtD
Nicardipine—Dizziness—Fluorouracil—head and neck cancer	0.000475	0.00422	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000473	0.00419	CcSEcCtD
Nicardipine—Insomnia—Docetaxel—head and neck cancer	0.000469	0.00416	CcSEcCtD
Nicardipine—Paraesthesia—Docetaxel—head and neck cancer	0.000466	0.00413	CcSEcCtD
Nicardipine—Dyspnoea—Docetaxel—head and neck cancer	0.000462	0.0041	CcSEcCtD
Nicardipine—Somnolence—Docetaxel—head and neck cancer	0.000461	0.00409	CcSEcCtD
Nicardipine—Vomiting—Fluorouracil—head and neck cancer	0.000457	0.00406	CcSEcCtD
Nicardipine—Dyspepsia—Docetaxel—head and neck cancer	0.000457	0.00405	CcSEcCtD
Nicardipine—Rash—Fluorouracil—head and neck cancer	0.000453	0.00402	CcSEcCtD
Nicardipine—Dermatitis—Fluorouracil—head and neck cancer	0.000453	0.00402	CcSEcCtD
Nicardipine—Headache—Fluorouracil—head and neck cancer	0.00045	0.004	CcSEcCtD
Nicardipine—Pain—Docetaxel—head and neck cancer	0.000444	0.00394	CcSEcCtD
Nicardipine—Constipation—Docetaxel—head and neck cancer	0.000444	0.00394	CcSEcCtD
Nicardipine—ABCB1—trachea—head and neck cancer	0.000439	0.00249	CbGeAlD
Nicardipine—CYP2D6—head—head and neck cancer	0.000428	0.00243	CbGeAlD
Nicardipine—Feeling abnormal—Docetaxel—head and neck cancer	0.000427	0.00379	CcSEcCtD
Nicardipine—Nausea—Fluorouracil—head and neck cancer	0.000427	0.00379	CcSEcCtD
Nicardipine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000424	0.00377	CcSEcCtD
Nicardipine—Body temperature increased—Docetaxel—head and neck cancer	0.00041	0.00364	CcSEcCtD
Nicardipine—Abdominal pain—Docetaxel—head and neck cancer	0.00041	0.00364	CcSEcCtD
Nicardipine—ABCB1—lymphoid tissue—head and neck cancer	0.000382	0.00217	CbGeAlD
Nicardipine—Hypersensitivity—Docetaxel—head and neck cancer	0.000382	0.00339	CcSEcCtD
Nicardipine—Asthenia—Docetaxel—head and neck cancer	0.000372	0.0033	CcSEcCtD
Nicardipine—Diarrhoea—Docetaxel—head and neck cancer	0.000355	0.00315	CcSEcCtD
Nicardipine—ABCB1—thyroid gland—head and neck cancer	0.000347	0.00197	CbGeAlD
Nicardipine—Dizziness—Docetaxel—head and neck cancer	0.000343	0.00304	CcSEcCtD
Nicardipine—Vomiting—Docetaxel—head and neck cancer	0.00033	0.00293	CcSEcCtD
Nicardipine—Rash—Docetaxel—head and neck cancer	0.000327	0.0029	CcSEcCtD
Nicardipine—Dermatitis—Docetaxel—head and neck cancer	0.000327	0.0029	CcSEcCtD
Nicardipine—Headache—Docetaxel—head and neck cancer	0.000325	0.00288	CcSEcCtD
Nicardipine—Nausea—Docetaxel—head and neck cancer	0.000308	0.00273	CcSEcCtD
Nicardipine—ABCB1—head—head and neck cancer	0.000308	0.00175	CbGeAlD
Nicardipine—ABCB1—lymph node—head and neck cancer	0.000216	0.00122	CbGeAlD
Nicardipine—CHRM3—Metabolism—PTEN—head and neck cancer	1.88e-05	6.66e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTEN—head and neck cancer	1.88e-05	6.66e-05	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	1.88e-05	6.65e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—PIK3CA—head and neck cancer	1.88e-05	6.65e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—AKT1—head and neck cancer	1.87e-05	6.63e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—AKT1—head and neck cancer	1.87e-05	6.63e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—PIK3CA—head and neck cancer	1.86e-05	6.58e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL2—head and neck cancer	1.86e-05	6.58e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.85e-05	6.57e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	1.85e-05	6.57e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—MAPK3—head and neck cancer	1.84e-05	6.52e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—MAPK3—head and neck cancer	1.84e-05	6.52e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MAPK1—head and neck cancer	1.82e-05	6.45e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—STAT3—head and neck cancer	1.82e-05	6.45e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EGFR—head and neck cancer	1.82e-05	6.45e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTEN—head and neck cancer	1.82e-05	6.44e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTEN—head and neck cancer	1.82e-05	6.44e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.81e-05	6.43e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.81e-05	6.42e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—MAPK1—head and neck cancer	1.81e-05	6.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EGFR—head and neck cancer	1.81e-05	6.41e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	1.81e-05	6.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—head and neck cancer	1.8e-05	6.39e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MAPK3—head and neck cancer	1.8e-05	6.37e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.76e-05	6.25e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—STAT3—head and neck cancer	1.76e-05	6.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—STAT3—head and neck cancer	1.76e-05	6.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—MAPK1—head and neck cancer	1.75e-05	6.2e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—MAPK1—head and neck cancer	1.75e-05	6.2e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—head and neck cancer	1.75e-05	6.2e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—head and neck cancer	1.75e-05	6.2e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	1.75e-05	6.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—head and neck cancer	1.74e-05	6.18e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—head and neck cancer	1.74e-05	6.18e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—HRAS—head and neck cancer	1.74e-05	6.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—MAPK3—head and neck cancer	1.74e-05	6.16e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—HRAS—head and neck cancer	1.74e-05	6.15e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	1.72e-05	6.09e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	1.71e-05	6.07e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MAPK1—head and neck cancer	1.71e-05	6.06e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—head and neck cancer	1.71e-05	6.06e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	1.7e-05	6.04e-05	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—AKT1—head and neck cancer	1.69e-05	6e-05	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—AKT1—head and neck cancer	1.69e-05	5.98e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MAPK3—head and neck cancer	1.68e-05	5.96e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MAPK3—head and neck cancer	1.68e-05	5.96e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—STAT3—head and neck cancer	1.68e-05	5.95e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL2—head and neck cancer	1.67e-05	5.94e-05	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	1.67e-05	5.92e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL2—head and neck cancer	1.67e-05	5.92e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	1.67e-05	5.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—MAPK1—head and neck cancer	1.65e-05	5.86e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—head and neck cancer	1.65e-05	5.86e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL2—head and neck cancer	1.65e-05	5.86e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	1.65e-05	5.84e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—PIK3CA—head and neck cancer	1.65e-05	5.84e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCND1—head and neck cancer	1.63e-05	5.79e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCND1—head and neck cancer	1.63e-05	5.77e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—STAT3—head and neck cancer	1.62e-05	5.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—STAT3—head and neck cancer	1.62e-05	5.76e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTEN—head and neck cancer	1.62e-05	5.73e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCND1—head and neck cancer	1.61e-05	5.71e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	1.61e-05	5.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MAPK3—head and neck cancer	1.6e-05	5.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MAPK1—head and neck cancer	1.6e-05	5.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MAPK1—head and neck cancer	1.6e-05	5.67e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—head and neck cancer	1.6e-05	5.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—head and neck cancer	1.6e-05	5.67e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—head and neck cancer	1.59e-05	5.65e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTEN—head and neck cancer	1.58e-05	5.61e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTEN—head and neck cancer	1.58e-05	5.6e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—PIK3CA—head and neck cancer	1.58e-05	5.6e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	1.58e-05	5.59e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PTEN—head and neck cancer	1.58e-05	5.58e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTEN—head and neck cancer	1.57e-05	5.57e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PTEN—head and neck cancer	1.57e-05	5.57e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—PIK3CA—head and neck cancer	1.57e-05	5.57e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.57e-05	5.56e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	1.56e-05	5.54e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PTEN—head and neck cancer	1.56e-05	5.51e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MAPK3—head and neck cancer	1.55e-05	5.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MAPK3—head and neck cancer	1.55e-05	5.5e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	1.55e-05	5.5e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—head and neck cancer	1.54e-05	5.45e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—head and neck cancer	1.53e-05	5.43e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—head and neck cancer	1.53e-05	5.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MAPK1—head and neck cancer	1.53e-05	5.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—head and neck cancer	1.53e-05	5.41e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—head and neck cancer	1.52e-05	5.41e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTEN—head and neck cancer	1.52e-05	5.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTEN—head and neck cancer	1.52e-05	5.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PIK3CA—head and neck cancer	1.52e-05	5.38e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PIK3CA—head and neck cancer	1.52e-05	5.38e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	1.52e-05	5.38e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	1.51e-05	5.36e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.51e-05	5.36e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.49e-05	5.29e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	1.49e-05	5.29e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—head and neck cancer	1.48e-05	5.26e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MAPK1—head and neck cancer	1.48e-05	5.23e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MAPK1—head and neck cancer	1.48e-05	5.23e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—head and neck cancer	1.48e-05	5.23e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—head and neck cancer	1.48e-05	5.23e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—head and neck cancer	1.46e-05	5.18e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—head and neck cancer	1.45e-05	5.15e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—head and neck cancer	1.44e-05	5.09e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—head and neck cancer	1.43e-05	5.09e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.43e-05	5.07e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—head and neck cancer	1.42e-05	5.04e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	1.42e-05	5.03e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	1.42e-05	5.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—head and neck cancer	1.42e-05	5.03e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.42e-05	5.02e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—head and neck cancer	1.41e-05	4.99e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—head and neck cancer	1.41e-05	4.98e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—head and neck cancer	1.41e-05	4.98e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	1.4e-05	4.98e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—head and neck cancer	1.4e-05	4.98e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	1.4e-05	4.97e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.4e-05	4.96e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—head and neck cancer	1.4e-05	4.95e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—head and neck cancer	1.39e-05	4.93e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—head and neck cancer	1.39e-05	4.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—head and neck cancer	1.39e-05	4.92e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	1.39e-05	4.92e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—head and neck cancer	1.37e-05	4.87e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—head and neck cancer	1.37e-05	4.85e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—head and neck cancer	1.37e-05	4.84e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—head and neck cancer	1.36e-05	4.83e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—head and neck cancer	1.35e-05	4.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—head and neck cancer	1.35e-05	4.79e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—head and neck cancer	1.35e-05	4.77e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK3—head and neck cancer	1.35e-05	4.77e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK3—head and neck cancer	1.34e-05	4.76e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	1.33e-05	4.71e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—head and neck cancer	1.33e-05	4.71e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	1.33e-05	4.7e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—head and neck cancer	1.32e-05	4.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—head and neck cancer	1.32e-05	4.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—head and neck cancer	1.32e-05	4.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—head and neck cancer	1.32e-05	4.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—head and neck cancer	1.31e-05	4.66e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—head and neck cancer	1.29e-05	4.57e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.29e-05	4.56e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—head and neck cancer	1.28e-05	4.55e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—head and neck cancer	1.28e-05	4.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—head and neck cancer	1.28e-05	4.55e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—head and neck cancer	1.28e-05	4.54e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—head and neck cancer	1.28e-05	4.54e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK1—head and neck cancer	1.28e-05	4.54e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—head and neck cancer	1.28e-05	4.54e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK1—head and neck cancer	1.28e-05	4.53e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.28e-05	4.53e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—head and neck cancer	1.28e-05	4.52e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—head and neck cancer	1.27e-05	4.51e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—head and neck cancer	1.27e-05	4.51e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	1.26e-05	4.48e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—head and neck cancer	1.26e-05	4.48e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	1.26e-05	4.47e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	1.26e-05	4.47e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—head and neck cancer	1.24e-05	4.4e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—head and neck cancer	1.24e-05	4.4e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	1.23e-05	4.37e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—head and neck cancer	1.23e-05	4.34e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—head and neck cancer	1.22e-05	4.33e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—head and neck cancer	1.21e-05	4.3e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—head and neck cancer	1.19e-05	4.22e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—head and neck cancer	1.19e-05	4.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—head and neck cancer	1.19e-05	4.21e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—head and neck cancer	1.19e-05	4.2e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—head and neck cancer	1.19e-05	4.2e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—head and neck cancer	1.18e-05	4.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—head and neck cancer	1.17e-05	4.15e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—head and neck cancer	1.15e-05	4.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—head and neck cancer	1.15e-05	4.07e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.14e-05	4.04e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	1.14e-05	4.04e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—head and neck cancer	1.14e-05	4.03e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—head and neck cancer	1.14e-05	4.03e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—head and neck cancer	1.13e-05	4.02e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—head and neck cancer	1.13e-05	4.02e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK3—head and neck cancer	1.12e-05	3.98e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.12e-05	3.98e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.12e-05	3.96e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.11e-05	3.95e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—head and neck cancer	1.11e-05	3.95e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—head and neck cancer	1.11e-05	3.94e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—head and neck cancer	1.11e-05	3.93e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—head and neck cancer	1.11e-05	3.93e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	1.1e-05	3.89e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	1.09e-05	3.88e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK3—head and neck cancer	1.09e-05	3.85e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK3—head and neck cancer	1.09e-05	3.85e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—head and neck cancer	1.08e-05	3.84e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—head and neck cancer	1.08e-05	3.84e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—head and neck cancer	1.08e-05	3.81e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—head and neck cancer	1.07e-05	3.8e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—head and neck cancer	1.07e-05	3.8e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—head and neck cancer	1.07e-05	3.8e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK1—head and neck cancer	1.07e-05	3.79e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—head and neck cancer	1.07e-05	3.79e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—head and neck cancer	1.06e-05	3.76e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	1.06e-05	3.75e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—head and neck cancer	1.05e-05	3.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—head and neck cancer	1.05e-05	3.71e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK1—head and neck cancer	1.03e-05	3.67e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK1—head and neck cancer	1.03e-05	3.67e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—head and neck cancer	1.03e-05	3.66e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—head and neck cancer	1.03e-05	3.66e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—head and neck cancer	1.03e-05	3.64e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—head and neck cancer	1.02e-05	3.63e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—head and neck cancer	1.01e-05	3.6e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	1.01e-05	3.59e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	1.01e-05	3.57e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	9.65e-06	3.42e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—head and neck cancer	9.31e-06	3.3e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—head and neck cancer	9.28e-06	3.29e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—head and neck cancer	9.12e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—head and neck cancer	9.1e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—head and neck cancer	9.08e-06	3.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—head and neck cancer	9.06e-06	3.21e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—head and neck cancer	9.05e-06	3.21e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—head and neck cancer	8.97e-06	3.18e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—head and neck cancer	8.97e-06	3.18e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—head and neck cancer	8.97e-06	3.18e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—head and neck cancer	8.96e-06	3.18e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	8.94e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—head and neck cancer	8.77e-06	3.11e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—head and neck cancer	8.77e-06	3.11e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—head and neck cancer	8.68e-06	3.08e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—head and neck cancer	8.68e-06	3.08e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	8.61e-06	3.05e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—head and neck cancer	8.58e-06	3.04e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.42e-06	2.98e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—head and neck cancer	8.41e-06	2.98e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—head and neck cancer	8.3e-06	2.94e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—head and neck cancer	8.3e-06	2.94e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	7.92e-06	2.81e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—head and neck cancer	7.88e-06	2.79e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	7.85e-06	2.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—head and neck cancer	7.58e-06	2.69e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—head and neck cancer	7.34e-06	2.6e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—head and neck cancer	7.33e-06	2.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—head and neck cancer	7.33e-06	2.6e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—head and neck cancer	7.04e-06	2.49e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—head and neck cancer	6.87e-06	2.43e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—head and neck cancer	6.47e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—head and neck cancer	6.42e-06	2.27e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.18e-06	1.84e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—head and neck cancer	4.23e-06	1.5e-05	CbGpPWpGaD
